China Looks To Step Up Overseas GMP Inspections With New Draft Guidance
This article was originally published in The Gold Sheet
Executive Summary
China’s SFDA releases draft guidance on overseas GMP inspections, which requires foreign pharmaceutical companies to submit additional documentation, including sales, import and production reports spanning three years.